4-Major Breakthrough in Lung Cancer Treatment Unveiled: Osimertinib's Remarkable Impact

▴ lung cancer
This medication has proven to be a game-changer, demonstrating a substantial reduction in the five-year risk of recurrent cancer by an impressive 73% and decreasing the risk of death by an equally remarkable 51%.

Medical science has achieved a significant victory in the battle against lung cancer, marking a milestone in the field. The New England Journal of Medicine has reported a major breakthrough, shedding light on the extraordinary efficacy of the medication Osimertinib, commercially known as Tagrisso. According to a comprehensive report by Fox News Digital, this medication has proven to be a game-changer, demonstrating a substantial reduction in the five-year risk of recurrent cancer by an impressive 73% and decreasing the risk of death by an equally remarkable 51%.  

Dr. Faiz Y. Bhora, the Chief of Thoracic Surgery and Central Region Chair of Surgery at Hackensack Meridian Health in New Jersey, expressed his enthusiasm about the groundbreaking results. In an exclusive interaction with Fox News Digital, Dr. Bhora emphasized the unprecedented progress, noting that oncologists were content with a 5% or 10% improvement, and now, the focus is on an exceptional advancement exceeding 50% in terms of survival.  

Dr. Bhora shared his personal experience, revealing that he has recommended the medication to numerous lung cancer patients, witnessing positive outcomes. "We're truly in the era of personalized medicine. We now have a lot of targeted therapies that work well for patients who have mutations in their tumours," added Dr Bhora.  

The effectiveness of Tagrisso extends to patients with a specific genetic mutation called EGFRm who have undergone surgery. Dr Bhora explained that the pill plays a crucial role in preventing recurrence post-tumour removal for individuals with this genetic marker.

 Dr. Bhora sheds light on a common misconception about lung cancer, dispelling the notion that it solely affects smokers. Lung cancer is not confined to a specific demographic; over 30% of individuals diagnosed have never smoked, with a notable number being women. This revelation reshapes our understanding of the disease, emphasizing the need for broader awareness and targeted interventions.  

As the medical community celebrates this remarkable achievement, the era of personalized medicine opens new doors for targeted therapies, offering hope to a broader spectrum of lung cancer patients. The impact of Osimertinib, with its brand name Tagrisso, resonates as a ray of progress in the relentless pursuit of effective cancer treatments.

Tags : #lungcancer #Osimertinib #Tagrisso #cancermedicine #cancercare #cancerawareness #medicircle

About the Author

Sunny Parayan

Hey there! I'm Sunny, a passionate writer with a strong interest in the healthcare domain! When I'm not typing on my keyboard, I watch shows and listen to music. I hope that through my work, I can make a positive impact on people's lives by helping them live happier and healthier.

View Profile

Related Stories

Loading Please wait...


Trending Now

Exploring the Link Between Covid-19 Vaccination and Sudden Cardiac Arrests: ICMR StudyNovember 22, 2023
Powering the Future: China's Biodegradable Wireless System for Bioelectronic InnovationNovember 22, 2023
IMS BHU Pioneers Advanced Cardiac Care: Unveiling Cutting-Edge Technologies for Precise DiagnosisNovember 18, 2023
Inito's $6 Million Boost: Transforming Women's Health with AI-Backed Fertility MonitoringNovember 18, 2023
Madras High Court Advocates for Equality: PG Medical Students to Receive Incentive Marks for COVID-19 DutyNovember 18, 2023
Next-Gen Healthcare: CarePods and AI Redefine the Patient ExperienceNovember 17, 2023
Air Quality Crisis: Alarming Rise in Premature Births Linked to Air Quality in Begusarai, BiharNovember 17, 2023
Limerick Contest-2023: A Celebration of Wit and PoetryNovember 17, 2023
IIIT-Hyderabad among top 100 institutions for 5G Use Case LabNovember 17, 2023
Powerful, motivating and inspiring talks marked TEDx Hyderabad Women 2023 which was held with the theme "Two Steps ForwardNovember 17, 2023
Speaking the Diagnosis: How AI in Voice Analysis Is Revolutionizing Diabetes DetectionNovember 17, 2023
FDA Approves Zepbound: A New Medication for Weight Loss by Eli LillyNovember 17, 2023
CoverSelf Raises $8.2 Million in Seed Funding to Revolutionize Healthcare Claims with Innovative Fintech PlatformNovember 16, 2023
From Miracle to Medic: The Extraordinary Journey of India's First Paediatric Liver Transplant RecipientNovember 16, 2023
Combatting Chikungunya: Valneva's Chikungunya Vaccine Cleared by USFDA, Eyes India LaunchNovember 16, 2023
Global Corporate Summit 2023 with the theme Unlocking Opportunities in a Dynamic World heldNovember 16, 2023
2nd IHub-Data Mobility Summit heldNovember 16, 2023
Revolutionary AI-powered technology detects multiple abdominal pathologies simultaneouslyNovember 16, 2023
1 Out of 3 Stroke Patients Suffer Long-Term Health Complications, Says NeurologistNovember 16, 2023
Amrita Hospital, Kochi, Launches App for People with Swallowing DifficultiesNovember 15, 2023